PMC5322173_01
Endoscopic image of the tumor in the lower esophagus.
gr1.jpg
PMC5322173_01_gr1.jpg
fig0005
A new endoscopy revealed a solid mass on the lower third of the esophagus (Fig. 1).
Pneumo-computed tomography showing thickening of the esophageal wall and regional lymph nodes.
gr2.jpg
PMC5322173_01_gr2.jpg
fig0010
Staging was completed with a multislice computed tomography scan, using a distention technique with carbon dioxide, which confirmed the presence of a large tumor in the lower esophagus with evidence of regional lymph node involvement (Fig. 2).
Primary tumor, metastatic locoregional lymph node and liver metastasis on PET-CT scan.
gr3.jpg
PMC5322173_01_gr3.jpg
fig0015
During re-staging prior to surgery, a Positron Emission Tomography/Computed Tomography (PET/CT) showed two metabolically active liver images with Standardized Uptake Values (SUV) of 5.8 and 4.1, compatible with metastatic disease (Fig. 3).